These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 35607879)
1. Effect of levetiracetam on nocturnal sleep in patients with epilepsy. Chaneva OG; Viteva EI Neurol Neurochir Pol; 2022; 56(4):357-364. PubMed ID: 35607879 [TBL] [Abstract][Full Text] [Related]
2. Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers. Cicolin A; Magliola U; Giordano A; Terreni A; Bucca C; Mutani R Epilepsia; 2006 Jan; 47(1):82-5. PubMed ID: 16417535 [TBL] [Abstract][Full Text] [Related]
3. The acute effects of levetiracetam on nocturnal sleep and daytime sleepiness in patients with partial epilepsy. Zhou JY; Tang XD; Huang LL; Zhong ZQ; Lei F; Zhou D J Clin Neurosci; 2012 Jul; 19(7):956-60. PubMed ID: 22595355 [TBL] [Abstract][Full Text] [Related]
4. Effects of levetiracetam on sleep in normal volunteers. Bazil CW; Battista J; Basner RC Epilepsy Behav; 2005 Nov; 7(3):539-42. PubMed ID: 16165400 [TBL] [Abstract][Full Text] [Related]
5. Comparison of motor activity and sleep in patients with complex partial seizures on levetiracetam treatment and a group of healthy subjects. Yilmaz H Behav Neurol; 2007; 18(3):165-70. PubMed ID: 17726245 [TBL] [Abstract][Full Text] [Related]
6. The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy. Cho YW; Kim DH; Motamedi GK Seizure; 2011 May; 20(4):336-9. PubMed ID: 21316267 [TBL] [Abstract][Full Text] [Related]
7. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy. Abou-Khalil B; Hemdal P; Privitera MD Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078 [TBL] [Abstract][Full Text] [Related]
8. The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy. Bell C; Vanderlinden H; Hiersemenzel R; Otoul C; Nutt D; Wilson S J Sleep Res; 2002 Sep; 11(3):255-63. PubMed ID: 12220322 [TBL] [Abstract][Full Text] [Related]
9. Effects of levetiracetam on sleep architecture and daytime sleepiness. Chaneva O Folia Med (Plovdiv); 2021 Oct; 63(5):631-636. PubMed ID: 35851195 [TBL] [Abstract][Full Text] [Related]
10. Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study. Attilakos A; Dinopoulos A; Tsirouda M; Paschalidou M; Prasouli A; Stamati A; Parasxou N; Garoufi A Epilepsy Res; 2019 Sep; 155():106162. PubMed ID: 31301589 [TBL] [Abstract][Full Text] [Related]
11. Levetiracetam monotherapy--outcomes from an epilepsy clinic. Stephen LJ; Kelly K; Parker P; Brodie MJ Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583 [TBL] [Abstract][Full Text] [Related]
12. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573 [TBL] [Abstract][Full Text] [Related]
13. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy. Shukla G; Gupta A; Agarwal P; Poornima S Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024 [TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study. Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275 [TBL] [Abstract][Full Text] [Related]
15. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Ben-Menachem E; Edrich P; Van Vleymen B; Sander JW; Schmidt B Epilepsy Res; 2003 Feb; 53(1-2):57-64. PubMed ID: 12576168 [TBL] [Abstract][Full Text] [Related]
16. Levetiracetam for people with mental retardation and refractory epilepsy. Kelly K; Stephen LJ; Brodie MJ Epilepsy Behav; 2004 Dec; 5(6):878-83. PubMed ID: 15582836 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial. Muñana KR; Thomas WB; Inzana KD; Nettifee-Osborne JA; McLucas KJ; Olby NJ; Mariani CJ; Early PJ J Vet Intern Med; 2012; 26(2):341-8. PubMed ID: 22295869 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial. Glauser TA; Pellock JM; Bebin EM; Fountain NB; Ritter FJ; Jensen CM; Shields WD Epilepsia; 2002 May; 43(5):518-24. PubMed ID: 12027913 [TBL] [Abstract][Full Text] [Related]
19. Relationship between bone density and levetiracetam monotherapy in epilepsy patients. Gözükızıl ST; Aydın Z; Yalçın AD Clin Neurol Neurosurg; 2022 Jul; 218():107270. PubMed ID: 35623138 [TBL] [Abstract][Full Text] [Related]
20. Levetiracetam monotherapy for elderly patients with epilepsy. Alsaadi TM; Koopmans S; Apperson M; Farias S Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]